HORIZON HEALTHCARE — All Prescriptions & Medications — Page 13
Practice Code: C81006 | DERBY, DE1 1TH
Showing results 601-650 of 681
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ciclosporin | 14 | 1,600 | £2.2K | -16.1% ▼ |
| Calcitriol | 14 | 1,272 | £349 | -10.3% ▼ |
| Timolol and brimonidine | 14 | 205 | £530 | -0.2% vs avg |
| 14 | 165 | £15 | -62.8% ▼ | |
| 14 | 750 | £1.6K | -64.9% ▼ | |
| 14 | 1,120 | £602 | +157.3% ▲ | |
| 14 | 164 | £785 | +106.3% ▲ | |
| 14 | 105 | £223 | -4.1% ▼ | |
| 14 | 770 | £2.0K | +73.3% ▲ | |
| 14 | 500 | £3.0K | +21.7% ▲ | |
| 14 | 420 | £2.7K | +9.6% ▲ | |
| Budesonide | 13 | 666 | £1.1K | -17.0% ▼ |
| Opicapone | 13 | 390 | £767 | -32.1% ▼ |
| Trihexyphenidyl hydrochloride | 13 | 1,092 | £49 | -54.2% ▼ |
| Buprenorphine hydrochloride | 13 | 728 | £152 | -97.9% ▼ |
| Betamethasone sodium phosphate | 13 | 953 | £125 | +5.7% ▲ |
| Oestrogens conjugated | 13 | 1,148 | £350 | -36.3% ▼ |
| Etodolac | 13 | 364 | £180 | -53.0% ▼ |
| Atropine sulfate | 13 | 1,120 | £919 | +2.0% ▲ |
| Mometasone furoate/olopatadine hydrochloride | 13 | 13 | £165 | +19.7% ▲ |
| Emulsifying wax | 13 | 6,500 | £56 | +6.7% ▲ |
| Malathion | 13 | 1,950 | £185 | +103.5% ▲ |
| 13 | 78 | £172 | +106.0% ▲ | |
| 13 | 130 | £403 | -36.1% ▼ | |
| 13 | 1,700 | £189 | +94.3% ▲ | |
| 13 | 540 | £2.2K | +9.8% ▲ | |
| 13 | 190 | £328 | -24.5% ▼ | |
| 13 | 450 | £954 | +18.8% ▲ | |
| Ofloxacin | 12 | 316 | £303 | +46.0% ▲ |
| Ivermectin | 12 | 56 | £731 | +23.0% ▲ |
| Indoramin | 12 | 1,012 | £820 | -21.1% ▼ |
| Cyanocobalamin | 12 | 912 | £101 | -96.6% ▼ |
| RtS 1.3 kcal/g dessert style (fruit based) (0913051) | 12 | 111.3K | £2.4K | +130.6% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 12 | 14.4K | £224 | -47.6% ▼ |
| Clindamycin phosphate | 12 | 660 | £111 | -27.0% ▼ |
| Lidocaine | 12 | 340 | £184 | +4.4% ▲ |
| 12 | 720 | £1.5K | +44.1% ▲ | |
| 12 | 600 | £325 | +43.2% ▲ | |
| 12 | 2,400 | £466 | -18.3% ▼ | |
| 12 | 1,990 | £164 | -29.0% ▼ | |
| 12 | 22 | £372 | +76.4% ▲ | |
| 12 | 390 | £1.2K | +73.9% ▲ | |
| 12 | 720 | £2.5K | +8.8% ▲ | |
| Disopyramide | 11 | 1,232 | £198 | +70.8% ▲ |
| Citalopram hydrochloride | 11 | 270 | £193 | -31.5% ▼ |
| Almotriptan | 11 | 36 | £79 | -11.3% ▼ |
| Insulin glulisine | 11 | 85 | £481 | -48.7% ▼ |
| Phased formulations of ethinylestradiol | 11 | 966 | £46 | +146.5% ▲ |
| Cyproterone acetate | 11 | 308 | £417 | +0.2% vs avg |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 11 | 338 | £943 | -58.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.